Axinn’s biotechnology team is led by a former medical school professor and other lawyers and professionals with doctoral level degrees in areas such as molecular biology and immunology. They also have over 50 years of industry experience. Axinn attorneys are highly qualified to provide effective legal, scientific and business solutions in the most sophisticated areas of the field. The firm works extensively in cutting-edge areas such as nanoparticle technologies, adult stem-cell-based tissue graft technologies, monoclonal antibodies and other peptide/protein-based treatments. The firm also represents a number of major research-based universities.